- 01Welcome and Thank You from Our Interim President & CEO
- 022021 UC Health Fast Facts
- 03Providing Hope to Our Community Through Research
- 04Highlights from the University of Cincinnati Gardner Neuroscience Institute
- 05Highlights from the University of Cincinnati Cancer Center
- 06UC Health Launches Region’s First Post-COVID-19 Clinic
- 07Father of Two Recovers from COVID-19 After Six Weeks at UC Medical Center
- 08COVID-19 Milestones in the Community
- 092021 Community Highlights
- 10UC Health Expands Support for Trauma Survivors
- 11UC Health Performs First Triple-Valve Endoscopic Procedure in U.S.
- 12Nurses of UC Health: Live to Serve and Love to Save
- 13UC Health Nurses Lead the Way
- 14Investing in Our People and Our Facilities
- 15UC Health’s Commitment to Diversity, Equity and Inclusion
- 16Your Support Makes a Difference
03Providing Hope to Our Community Through Research
UC Health’s partnership with the University of Cincinnati College of Medicine leads to innovative and breakthrough treatment options that allow our teams to give more hope to patients and their families. Here are just some of the highlights from the UC College of Medicine over the past year.
Immunotherapy Drug Bolsters Head and Neck Cancer Treatment
A UC clinical trial that added an immunotherapy drug to standard of care treatment regimens has shown increased survival rates for head and neck cancer patients with intermediate risk features.
Trisha Wise-Draper, MD, PhD, UC Health head and neck subspecialist and associate professor in the Department of Internal Medicine at the UC College of Medicine, led the trial and was the lead author on a paper detailing its findings that was recently published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
Read the full story here: https://www.uc.edu/news.html
Pioneering Stroke Treatment
For decades, UC researchers have been pioneers in the field of stroke research.
Joseph Broderick, MD, director of the UC Gardner Neuroscience Institute and professor in the Department of Neurology and Rehabilitation Medicine at the UC College of Medicine, and his colleagues at UC are continuing to lead the field of research in an effort to find the first proven treatment for stroke due to intracerebral hemorrhage, when blood vessels in the brain rupture and cause bleeding in the brain. He is the contact principal investigator for a global trial called FASTEST.
Read the full story here: https://www.uc.edu/news/articles/2021/12/uc-researchers-lead-stroke-trial.html
UC Researcher Receives Patent for New Breast Cancer Treatment
Much like a battle, certain breast cancers are able to build up their defenses and develop resistance to current treatments, but UC researcher Xiaoting Zhang and his team have recently been awarded a patent for new technology that could remove a key breast cancer co-driver and prevent the cancer from growing and resisting treatment.
Read the full story here: https://www.uc.edu/news/articles/2021/10/uc-researcher-awarded-rna-breast-cancer-treatment-patent.html
